Response to COVID-19 booster vaccinations in seronegative people with MS

Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, David Baker, Randy Chance, Nikos Evangelou, Katila George, Gavin Giovannoni, Katharine E Harding, Aimee Hibbert, Gillian Ingram, Stephen Jolles, Meleri Jones, Angray S Kang, Samantha Loveless, Stuart J Moat, Neil P Robertson, Francesca Rios, Klaus Schmierer, Mark Willis, Andrew Godkin, Ruth Dobson
doi: https://doi.org/10.1101/2022.03.12.22272083

Article Information

doi 
https://doi.org/10.1101/2022.03.12.22272083
History 
  • March 13, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Emma C Tallantyre, PhD FRCP1,2,
  2. Martin J Scurr, PhD*,3,4,
  3. Nicola Vickaryous, PhD*,5,
  4. Aidan Richards*,1,
  5. Valerie Anderson, PhD1,
  6. David Baker, PhD6,
  7. Randy Chance, MSc6,8,
  8. Nikos Evangelou, DPhil FRCP9,
  9. Katila George, BSc5,
  10. Gavin Giovannoni, PhD FRCP5,6,10,
  11. Katharine E Harding, PhD MRCP11,
  12. Aimee Hibbert, BSc9,
  13. Gillian Ingram, MD MRCP12,
  14. Stephen Jolles, PhD FRCP FRCPath3,7,
  15. Meleri Jones, PhD6,
  16. Angray S Kang, PhD6,8,
  17. Samantha Loveless, PhD1,
  18. Stuart J Moat, PhD13,14,
  19. Neil P Robertson, MD FRCP1,2,
  20. Francesca Rios, MSc5,
  21. Klaus Schmierer, PhD FRCP6,10,
  22. Mark Willis, PhD MRCP2,
  23. Andrew Godkin, MD FRCP3,4 and
  24. Ruth Dobson, PhD FRCP$,5,10
  1. 1Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, UK
  2. 2Department of Neurology, University Hospital of Wales, Cardiff, UK
  3. 3Division of Infection and Immunity, School of Medicine, Cardiff University, UK
  4. 4ImmunoServ Ltd, Cardiff, CF15 7AB, UK
  5. 5Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University London, UK
  6. 6Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK
  7. 7Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK
  8. 8Centre for Oral Immunobiology and Regenerative Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK
  9. 9Department of Clinical Neurology, University of Nottingham, UK
  10. 10Department of Neurology, Barts Health NHS Trust, London, UK
  11. 11Department of Neurology, Royal Gwent Hospital, Newport, UK
  12. 12Department of Neurology, Morriston Hospital, Swansea, UK
  13. 13Wales Newborn Screening Laboratory, Department of Medical Biochemistry, Immunology and Toxicology, University Hospital of Wales, Cardiff, Wales, UK
  14. 14School of Medicine, Cardiff University, UK
  1. ↵$Corresponding author: Dr Ruth Dobson, Preventive Neurology Unit, Wolfson Institute of Population Health, Charterhouse Square, EC1M 6BQ, Ruth.dobson{at}qmul.ac.uk, @drruthdobson

  1. ↵* These authors contributed equally

Back to top
Posted March 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Response to COVID-19 booster vaccinations in seronegative people with MS
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, David Baker, Randy Chance, Nikos Evangelou, Katila George, Gavin Giovannoni, Katharine E Harding, Aimee Hibbert, Gillian Ingram, Stephen Jolles, Meleri Jones, Angray S Kang, Samantha Loveless, Stuart J Moat, Neil P Robertson, Francesca Rios, Klaus Schmierer, Mark Willis, Andrew Godkin, Ruth Dobson
medRxiv 2022.03.12.22272083; doi: https://doi.org/10.1101/2022.03.12.22272083
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area